Article

NUSAP1 and KIAA0101 downregulation by neo-adjuvant therapy is associated with better outcome and survival in breast cancer.

2020-08-03

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Studies of molecular changes occurring before and after neo-adjuvant chemotherapy (NCT) for breast cancer may unveil genetic biomarkers to predict therapy response. This study aimed at identifying genomic changes in breast primary tumors of patients under NCT. Gene expression changes were correlated with pathological response and survival.<bold>Methods: </bold>G...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 30c0fd06-bdf2-5e32-941e-23da95b8009b
DOI: 10.21203/rs.3.rs-49283/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

NUSAP1 and KIAA0101 downregulation by neo-adjuvant therapy is associated with better outcome and survival in breast cancer.DOI 10.21203/rs.3.rs-49283/v1Read

A novel gene signature to predict response to neoadjuvant chemotherapy and endocrine treatment in estrogen receptor-positive breast cancer patientsSemantic proximity Read

Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancerSemantic proximity Read

Differential Gene -Based Predictors of Neoadjuvant Chemotherapy Efficacy in Breast CancerSemantic proximity Read

A three lncRNA set: AC009975.1, POTEH-AS1 and AL390243.1 as nodal efficacy biomarker of neoadjuvant therapy for HER-2 positive breast cancerSemantic proximity Read

Identification of a NACC1-Regulated Gene Signature Impli-Cated in the Features of Triple-Negative Breast CancerSemantic proximity Read

Predictive factors for response to neoadjuvant therapy in breast cancer.Semantic proximity Read

Changes in Expression of Genes Representing Key Biologic Processes after Neoadjuvant Chemotherapy in Breast Cancer, and Prognostic Implications in Residual DiseaseSemantic proximity Read

Reversal of endocrine resistance via N6AMT1-NEDD4L pathway-mediated p110α degradationSemantic proximity Read

The analysis of transcriptomic signature of TNBC – searching for the potential RNA-based predictive biomarkers to determine the chemotherapy sensitivitySemantic proximity Read

Gene expression before and after neoadjuvant chemotherapy or endocrine therapy and survival outcomes in hormone receptor-positive, HER2-negative breast cancer: the NEOENDO studySemantic proximity Read

Early Identification of Breast Cancer Patients Achieving Radiological Complete Response to NAC: A Clinicopathological and MRI-Based ApproachSemantic proximity Read

Neoadjuvant Chemotherapy in early-stage breast cancer: the trend over time and the impact on axillary management, A National Cancer Database AnalysisSemantic proximity Read